Assessing gains in diagnostic utility when human papillomavirus testing is used as an adjunct to Papanicolaou smear in the triage of women with cervical cytologic abnormalities

American Journal of Obstetrics and Gynecology

Volumn 181, Issue 2, 1999, Pages 382-386

  Franco, Eduardo L ^a   Ferenczy, Alex ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Cervical intraepithelial neoplasia; Human papillomavirus; Screening; Triage of cervical lesions

Indexed keywords

CANCER SCREENING; CARCINOGENESIS; CONFERENCE PAPER; DIAGNOSTIC VALUE; FEMALE; HUMAN; PAPANICOLAOU TEST; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX DISEASE; VIRUS DETECTION; VIRUS PATHOGENESIS; WART VIRUS;

EID: 0032820076     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9378(99)70586-7     Document Type: Conference Paper

References (10)

1. 1. Cox JT, Schiftman MH, Winzelberg AJ, Patterson JM. An evaluation of human papillomavirus testing as part of referral to colposcopy clinics, Obstet Gynecol 1992;80:389-95.
2. 2. Cox JT, Lorincz AT, Schiffman MH, Sherman ME, Cullen A, Kurman RJ. Human papillomavirus testing by Hybrid Capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 1995;172:946-54.
3. 3. Hatch KD, Schneider A, Abdel-Nour MW. An evaluation of human papillomavirus testing for intermediate-and high-risk types as triage before colposcopy. Am J Obstet Gynecol 1995;172:1150-5.
4. 4. Wright TC, Sun XW, Koulos J. Comparison of management algorithms for the evaluation of women with low-grade cytologic abnormalities. Obstet Gynecol 1995;85:202-10.
5. 5. Schneider A, Zahin DM, Kirchmayr R, Schneider VL. Screening for cervical intraepithelial neoplasia grade 2/3; validity of cytologic study, cervicography, and human papillomavirus detection. Am J Obstet Gynecol 1996;174:1534-41.
6. 6. Ferenczy A, Franco E, Arseneau J, Wright TC, Richart RM. Diagnostic performance of Hybrid Capture human papillomavirus deoxyribonucleic acid assay combined with liquidbased cytologic study. Am J Obstet Gynecol 1996;175:651-6.
7. 7. Kaufman RH, Adam E, Icenogle J, Reeves WC. Human papillomavirus testing as triage for atypical squamous cells of undetermined significance and low-grade squamous intracpithelial lesions: sensitivity, specificity, and cost-effectiveness. Am J Obstet Gynecol 1997;177:930-6.
8. 8. Solomon D, The 1988 Bethesda system for reporting cervical/vaginal cytologic diagnoses: developed and approved at the National Cancer Institute Workshop, Bethesda, Maryland, December 12-13, 1988. J Clin Cytol Cytopathol 1989;33:567-74.
9. 9. Wright TC, Lörincz A, Ferris DG, et al. Reflex human papillomavirus deoxyribonucleic acid testing in women with abnormal Papanicolaou smears. Am J Obstet Gynecol 1998;178:962-6.
10. 10. Lörincz A. Hybrid Capture method for detection of human papillomavirus DNA in clinical specimens. Papillomavirus Rep 1996;7:1-5.